Merit Medical Systems Operating Income 2010-2023 | MMSI
Merit Medical Systems operating income from 2010 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Merit Medical Systems Annual Operating Income (Millions of US $) |
2023 |
$124 |
2022 |
$88 |
2021 |
$61 |
2020 |
$-2 |
2019 |
$15 |
2018 |
$59 |
2017 |
$33 |
2016 |
$35 |
2015 |
$38 |
2014 |
$40 |
2013 |
$28 |
2012 |
$30 |
2011 |
$33 |
2010 |
$17 |
2009 |
$33 |
Merit Medical Systems Quarterly Operating Income (Millions of US $) |
2023-12-31 |
$34 |
2023-09-30 |
$35 |
2023-06-30 |
$29 |
2023-03-31 |
$26 |
2022-12-31 |
$30 |
2022-09-30 |
$19 |
2022-06-30 |
$23 |
2022-03-31 |
$15 |
2021-12-31 |
$22 |
2021-09-30 |
$16 |
2021-06-30 |
$9 |
2021-03-31 |
$14 |
2020-12-31 |
$16 |
2020-09-30 |
$0 |
2020-06-30 |
$-19 |
2020-03-31 |
$1 |
2019-12-31 |
$-3 |
2019-09-30 |
$-3 |
2019-06-30 |
$12 |
2019-03-31 |
$10 |
2018-12-31 |
$14 |
2018-09-30 |
$21 |
2018-06-30 |
$15 |
2018-03-31 |
$9 |
2017-12-31 |
$13 |
2017-09-30 |
$1 |
2017-06-30 |
$13 |
2017-03-31 |
$6 |
2016-12-31 |
$13 |
2016-09-30 |
$3 |
2016-06-30 |
$12 |
2016-03-31 |
$8 |
2015-12-31 |
$8 |
2015-09-30 |
$9 |
2015-06-30 |
$12 |
2015-03-31 |
$9 |
2014-12-31 |
$14 |
2014-09-30 |
$12 |
2014-06-30 |
$7 |
2014-03-31 |
$6 |
2013-12-31 |
$11 |
2013-09-30 |
$8 |
2013-06-30 |
$7 |
2013-03-31 |
$2 |
2012-12-31 |
$4 |
2012-09-30 |
$9 |
2012-06-30 |
$8 |
2012-03-31 |
$8 |
2011-12-31 |
$6 |
2011-09-30 |
$7 |
2011-06-30 |
$11 |
2011-03-31 |
$10 |
2010-12-31 |
$6 |
2010-09-30 |
$-3 |
2010-06-30 |
$9 |
2010-03-31 |
$6 |
2009-12-31 |
$8 |
2009-09-30 |
$8 |
2009-06-30 |
$9 |
2009-03-31 |
$8 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$4.369B |
$1.257B |
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
|